The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.
Jie SunFei FeiMingqing ZhangYuwei LiXipeng ZhangSiwei ZhuShiwu ZhangPublished in: BMC cancer (2019)
mSEPT9 analysis might be popularized as a routine biomarker for CRC screening. The combined detection of mSEPT9 and CECT can play an important role for recurrence monitoring. CIMP was highly associated with the pathological stage of CRC and dMMR.